NCT00478569View on ClinicalTrials.gov

Adherence to PTH(1-84) Treatment (FP-002-IM)

CompletedOBSERVATIONAL

Enrollment

1,179

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2013

Conditions

Clinical Use of PTH(1-84)

Interventions

DRUG

Parathyroid Hormone (PTH) (1-84)

Adherence to PTH(1-84) treatment in Usual Clinical Settings

Trial Locations (1)

4000

Nycomed, Roskilde

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Takeda

INDUSTRY